palmarumycin cp(1) has been researched along with diepoxin sigma in 1 studies
| Studies (palmarumycin cp(1)) | Trials (palmarumycin cp(1)) | Recent Studies (post-2010) (palmarumycin cp(1)) | Studies (diepoxin sigma) | Trials (diepoxin sigma) | Recent Studies (post-2010) (diepoxin sigma) |
|---|---|---|---|---|---|
| 8 | 0 | 1 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birmingham, A; Hopkins, TD; Jung, JK; Lazo, JS; Powis, G; Rodriguez, S; Southwick, EC; Wipf, P | 1 |
1 other study(ies) available for palmarumycin cp(1) and diepoxin sigma
| Article | Year |
|---|---|
New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead.
Topics: Antineoplastic Agents; Cell Division; Dioxanes; Drug Screening Assays, Antitumor; Epoxy Compounds; Humans; Naphthalenes; Naphthoquinones; Spiro Compounds; Thioredoxin-Disulfide Reductase; Thioredoxins; Tumor Cells, Cultured | 2001 |